EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Evaluation of the prognostic impact of pathologic tumor regression grade on patients with colorectal cancer after preoperative chemoradiotherapy

Eiichi Nakao, Michitaka Honda, Noriyuki Uesugi, Mitsumasa Osakabe, Ayaka Sato, Yukitoshi Todate, Mizunori Yaegashi, Yoshinao Takano, Akira Sasaki, Koji Kono, Tamotsu Sugai

Journal of Surgical Oncology · 2024

DOI: 10.1002/jso.27662 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2024. Verfasst von Eiichi Nakao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostic Pathology Center, Southern Tohoku General Hospital, Koriyama, Fukushima, Japan. Hauptthemen laut MEDLINE: Neoplasm Grading. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The prognostic value of the pathological response to preoperative chemoradiotherapy (CRT) in rectal cancer (RC) remains unknown.

Objectives

We aimed to assess the predictive value of the response to CRT that was derived from an evaluation of the histological findings (whole‐section vs. representative‐section sampling) and attempted to determine an objective cut‐off value for the tumor regression grade (TRG).

Methods

We examined the association of the TRG with the outcomes (recurrence‐free survival [RFS] and overall survival [OS]) of 78 patients with RC. Patients with RC treated with preoperative CRT were divided into development (30 cases) and validation (48 cases) cohorts. The TRG was classified as grades I (Ia, Ib), II, and III. The cut‐off value was determined by receiver operating characteristic (ROC) curve analysis.

Results

The TRG determined from whole‐section sampling versus representative‐section sampling was more strongly correlated with patient survival. We found that in both cohorts, patients with a cut‐off value of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm GradingHumansMaleFemaleMiddle AgedPrognosisAgedChemoradiotherapyAdultRetrospective StudiesColorectal NeoplasmsRectal NeoplasmsAged, 80 and overNeoadjuvant TherapySurvival RateROC CurveFollow-Up Studies

Stichwörter der Autor:innen

chemoradiotherapycut‐off valueprognosisrectal cancertumor regression grade

Autor:innen und Institutionen

  • Diagnostic Pathology Center, Southern Tohoku General Hospital, Koriyama, Fukushima, Japan.
  • Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University, Fukushima, Japan.
  • Division of Surgery, Southern Tohoku General Hospital, Koriyama, Fukushima, Japan.
  • Department of Molecular Diagnostic Pathology, School of Medicine, Iwate Medical University, Yahaba, Japan.
  • Department of Surgery, School of Medicine, Iwate Medical University, Yahaba, Japan.
  • Department of Gastrointestinal Surgery, Fukushima Medical University, Fukushima, Japan.

Zitieren

APA

Nakao, E., Honda, M., Uesugi, N., Osakabe, M., Sato, A., Todate, Y., Yaegashi, M., Takano, Y., Sasaki, A., Kono, K., & Sugai, T. (2024). Evaluation of the prognostic impact of pathologic tumor regression grade on patients with colorectal cancer after preoperative chemoradiotherapy. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27662

Vancouver

Nakao E, Honda M, Uesugi N, Osakabe M, Sato A, Todate Y, et al. Evaluation of the prognostic impact of pathologic tumor regression grade on patients with colorectal cancer after preoperative chemoradiotherapy. Journal of Surgical Oncology. 2024. doi:10.1002/jso.27662

BibTeX
@article{Nakao2024,
  author = {Nakao, Eiichi and Honda, Michitaka and Uesugi, Noriyuki and Osakabe, Mitsumasa and Sato, Ayaka and Todate, Yukitoshi and Yaegashi, Mizunori and Takano, Yoshinao and Sasaki, Akira and Kono, Koji and Sugai, Tamotsu},
  title = {Evaluation of the prognostic impact of pathologic tumor regression grade on patients with colorectal cancer after preoperative chemoradiotherapy},
  journal = {Journal of Surgical Oncology},
  year = {2024},
  doi = {10.1002/jso.27662}
}
Kostenlos starten →